title: Histone deacetylase inhibitors in cancer: what have we learned?
authors.affiliation: Department of Medical Oncology, Royal Melbourne Hospital, Parkville, Victoria, Australia.
authors.forename: James R
authors.initials: JR
authors.lastname: Whittle
authors.forename: Jayesh
authors.initials: J
authors.lastname: Desai
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D001572:Benzofurans / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage*; D005260:Female; D056572:Histone Deacetylase Inhibitors / Q000008:administration & dosage*; D006801:Humans; D006877:Hydroxamic Acids / Q000008:administration & dosage*; D008297:Male; D012509:Sarcoma / Q000188:drug therapy*
chemical_list: D000903:Antibiotics, Antineoplastic; D001572:Benzofurans; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D004317:Doxorubicin; C512352:abexinostat